| |
| |
|
| Insider
Information: |
Audhya Paul K. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
52,886 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$637,805 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
52,886 |
|
|
| Total
Value |
$637,805 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kalvista Pharmaceuticals Inc |
KALV |
|
2024-02-20 |
52,886 |
2022-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-02-20 |
4 |
S |
$14.12 |
$201,774 |
D/D |
(14,295) |
52,886 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,613 |
67,181 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-11-20 |
4 |
S |
$8.23 |
$65,711 |
D/D |
(7,985) |
36,568 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,530 |
44,553 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-08-18 |
4 |
S |
$10.73 |
$86,045 |
D/D |
(8,020) |
26,023 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,529 |
34,043 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-05-18 |
4 |
S |
$10.14 |
$28,201 |
D/D |
(2,780) |
13,014 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,447 |
15,794 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-02-17 |
4 |
S |
$7.66 |
$26,136 |
D/D |
(3,412) |
9,347 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,446 |
6,313 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-11-18 |
4 |
S |
$5.44 |
$3,928 |
D/D |
(722) |
5,946 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,419 |
6,668 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-08-17 |
4 |
S |
$14.96 |
$10,847 |
D/D |
(725) |
1,693 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,418 |
2,418 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
